Skip to main content
. 2020 Sep 4;29(2):262–270. doi: 10.1038/s41431-020-00719-3

Fig. 1. Flow chart, cohort overview.

Fig. 1

A total of 1700 in-house individuals were screened for suspected hereditary FSGS. Decision to include patients was based on prioritization criteria, which led to the inclusion of 19 index patients. In addition, five samples were sent in for molecular analysis. A total of 29% of the cases could be solved. A total of 68% of the patients did not show any clear disease-causing variant.